These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 11282255)
1. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Martinez D; Gelernter J; Abi-Dargham A; van Dyck CH; Kegeles L; Innis RB; Laruelle M Neuropsychopharmacology; 2001 May; 24(5):553-60. PubMed ID: 11282255 [TBL] [Abstract][Full Text] [Related]
2. Genotype influences in vivo dopamine transporter availability in human striatum. Heinz A; Goldman D; Jones DW; Palmour R; Hommer D; Gorey JG; Lee KS; Linnoila M; Weinberger DR Neuropsychopharmacology; 2000 Feb; 22(2):133-9. PubMed ID: 10649826 [TBL] [Abstract][Full Text] [Related]
3. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies. Costa A; Riedel M; Müller U; Möller HJ; Ettinger U Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331 [TBL] [Abstract][Full Text] [Related]
4. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949 [TBL] [Abstract][Full Text] [Related]
5. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Jacobsen LK; Staley JK; Zoghbi SS; Seibyl JP; Kosten TR; Innis RB; Gelernter J Am J Psychiatry; 2000 Oct; 157(10):1700-3. PubMed ID: 11007732 [TBL] [Abstract][Full Text] [Related]
6. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. van Dyck CH; Malison RT; Jacobsen LK; Seibyl JP; Staley JK; Laruelle M; Baldwin RM; Innis RB; Gelernter J J Nucl Med; 2005 May; 46(5):745-51. PubMed ID: 15872345 [TBL] [Abstract][Full Text] [Related]
7. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Barr CL; Xu C; Kroft J; Feng Y; Wigg K; Zai G; Tannock R; Schachar R; Malone M; Roberts W; Nöthen MM; Grünhage F; Vandenbergh DJ; Uhl G; Sunohara G; King N; Kennedy JL Biol Psychiatry; 2001 Feb; 49(4):333-9. PubMed ID: 11239904 [TBL] [Abstract][Full Text] [Related]
8. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Gelernter J; Kranzler HR; Satel SL; Rao PA Neuropsychopharmacology; 1994 Nov; 11(3):195-200. PubMed ID: 7865100 [TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics. Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gassó P; Catalan R; Mateos JJ; Lomeña F; Parellada E Schizophr Res; 2007 Feb; 90(1-3):115-22. PubMed ID: 17150335 [TBL] [Abstract][Full Text] [Related]
10. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Cheon KA; Ryu YH; Kim JW; Cho DY Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278 [TBL] [Abstract][Full Text] [Related]
11. Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders. Kugaya A; Fujita M; Innis RB Ann Nucl Med; 2000 Feb; 14(1):1-9. PubMed ID: 10770574 [TBL] [Abstract][Full Text] [Related]
12. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder. Roman T; Rohde LA; Hutz MH Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031 [TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849 [TBL] [Abstract][Full Text] [Related]
15. [Lack of association between VNTR polymorphism of DAT gene and schizophrenia]. Hauser J; Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Twardowska K; Rybakowski JK Psychiatr Pol; 2002; 36(3):403-12. PubMed ID: 12149916 [TBL] [Abstract][Full Text] [Related]
16. 123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia. Sjøholm H; Bratlid T; Sundsfjord J Psychopharmacology (Berl); 2004 Apr; 173(1-2):27-31. PubMed ID: 14712338 [TBL] [Abstract][Full Text] [Related]
17. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. van Dyck CH; Malison RT; Staley JK; Jacobsen LK; Seibyl JP; Laruelle M; Baldwin RM; Innis RB; Gelernter J Am J Psychiatry; 2004 Mar; 161(3):525-31. PubMed ID: 14992979 [TBL] [Abstract][Full Text] [Related]
18. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Malison RT; Best SE; van Dyck CH; McCance EF; Wallace EA; Laruelle M; Baldwin RM; Seibyl JP; Price LH; Kosten TR; Innis RB Am J Psychiatry; 1998 Jun; 155(6):832-4. PubMed ID: 9619159 [TBL] [Abstract][Full Text] [Related]
19. Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. Vandenbergh DJ; Bennett CJ; Grant MD; Strasser AA; O'Connor R; Stauffer RL; Vogler GP; Kozlowski LT Nicotine Tob Res; 2002 Aug; 4(3):333-40. PubMed ID: 12215242 [TBL] [Abstract][Full Text] [Related]
20. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Spencer TJ; Biederman J; Faraone SV; Madras BK; Bonab AA; Dougherty DD; Batchelder H; Clarke A; Fischman AJ Biol Psychiatry; 2013 Jul; 74(2):84-9. PubMed ID: 23273726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]